Association of ABCB1, μ-opioid Receptor, and Cytochrome P450 Genes with Methadone Dose in Iranian Male Addicts Under Methadone Therapy.  Golnezhad A, Torkaman-Boutorabi A, Mohammad Razaghi E, Zarrindast MR, Mahdavi MR, Vousooghi…

Single-Cell RNA Transcriptomics and Multi-omics Analyses Reveal the Clinical Effects of Acupuncture on Methadone Reduction.  Chen Y, Fan B, Zeng J, Zou Y, Tao C, Chen C, Zhang P, Liang J, Qi F, Tang H, Lu L.  Research (Wash D C). 2025 Ju…

Cortisol and β-Endorphin Responses During a Two-Month Exercise Training Program in Patients with an Opioid Use Disorder and on a Substitution Treatment.  Psarianos AE, Philippou A, Papadopetraki A, Chatzinikita E, Chryssanthopoulos C, Theos A…

Duration of Methadone and Buprenorphine-Naloxone Treatment.  Kleinman RA, Kurdyak P.  JAMA Netw Open. 2025 Jul 1;8(7):e2518389. doi: 10.1001/jamanetworkopen.2025.18389. PMID: 40591359; PMCID: PMC12215571. https://pmc.ncbi.nlm.nih.gov/ar…

Pain Management Strategies for Patients Receiving Extended-Release Buprenorphine for Opioid Use Disorder: A Scoping Review.  Azar P, Kim JJ, Azarmju F, Sirohi K, Machado J, Lau A, Siu J, Ignaszewski MJ, Montaner JSG, Krausz M.  Subst Use…

High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study.  Mordal J, Juya F, Holtan L, Vederhus JK, Opheim A, Brenna IH, Enger AE, Weimand B, Solli KK, Tanum L.&n…